$1.20
0.00%
Nasdaq, Oct 01, 04:17 pm EDT. Closed.
ISIN
US59503A1051
Symbol
MBOT

Microbot Medical Inc Target price 2026 - Analyst rating & recommendation

Microbot Medical Inc Classifications & Recommendation

Buy
89%
Hold
11%

Microbot Medical Inc Price Target

Target Price $4.08
Price $1.20
Potential
Number of Estimates 5
5 Analysts have issued a price target Microbot Medical Inc 2027 . The average Microbot Medical Inc target price is $4.08. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend Microbot Medical Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Microbot Medical Inc stock has an average upside potential 2027 of . Most analysts recommend the Microbot Medical Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 0.00 2.18

5 Analysts have issued a sales forecast Microbot Medical Inc 2026 . The average Microbot Medical Inc sales estimate is

$2.2m
unlock
. This is
521.43% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.7m 950.00%
unlock
, the lowest is
$976k 178.89%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $0.0
2027
$8.8m 306.44%
unlock
2028
$24.6m 178.08%
unlock
2029
$48.6m 97.51%
unlock

3 Analysts have issued an Microbot Medical Inc EBITDA forecast 2026. The average Microbot Medical Inc EBITDA estimate is

$-20.4m
unlock
. This is
10.51% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-21.0m 13.76%
unlock
, the lowest is
$-19.6m 6.18%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-14.7m 27.49%
2026
$-20.4m 38.78%
unlock
2027
$-24.5m 20.00%
unlock
2028
$-21.4m 12.50%
unlock
2029
$-2.4m 88.84%
unlock

EBITDA Margin

2027
-276.92% 70.48%
unlock
2028
-87.14% 68.53%
unlock

5 Microbot Medical Inc Analysts have issued a net profit forecast 2026. The average Microbot Medical Inc net profit estimate is

$-20.1m
unlock
. This is
22.95% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-19.8m 20.87%
unlock
, the lowest is
$-20.5m 25.15%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-13.1m 14.86%
2026
$-20.1m 52.89%
unlock
2027
$-20.6m 2.29%
unlock
2028
$-11.0m 46.67%
unlock
2029
$2.1m 118.80%
unlock

Net Margin

2027
-232.48% 74.84%
unlock
2028
-44.59% 80.82%
unlock
2029
4.23% 109.49%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.29 -0.30
60.27% 3.45%
P/E negative
EV/Sales 6.08

5 Analysts have issued a Microbot Medical Inc forecast for earnings per share. The average Microbot Medical Inc EPS is

$-0.30
unlock
. This is
25.00% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.30 25.00%
unlock
, the lowest is
$-0.29 20.83%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.29 60.27%
2026
$-0.30 3.45%
unlock
2027
$-0.31 3.33%
unlock
2028
$-0.16 48.39%
unlock
2029
$0.03 118.75%
unlock

P/E ratio

Current -5.00 47.21%
2026
-4.01 19.80%
unlock
2027
-3.92 2.24%
unlock
2028
-7.35 87.50%
unlock
2029
39.22 633.61%
unlock

Based on analysts' sales estimates for 2026, the Microbot Medical Inc stock is valued at an EV/Sales of

and an P/S ratio of
37.06
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 37.79
2026
6.08 83.90%
unlock
2027
1.50 75.40%
unlock
2028
0.54 64.04%
unlock
2029
0.27 49.37%
unlock

P/S ratio

Current
2026
37.06 83.91%
unlock
2027
9.12 75.40%
unlock
2028
3.28 64.04%
unlock
2029
1.66 49.37%
unlock

Current Microbot Medical Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
B. Riley Securities
Locked
➜
Locked
Locked Aug 14 2026
LUCID CAPITAL MARKETS
Locked
➜
Locked
Locked Jun 03 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Apr 14 2026
B. Riley Securities
Locked
➜
Locked
Locked Feb 10 2026
Roth Capital
Locked
➜
Locked
Locked Dec 03 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Nov 28 2025
HC Wainwright & Co.
Locked
➜
Locked
Locked Oct 15 2025
Analyst Rating Date
Locked
B. Riley Securities:
Locked
➜
Locked
Aug 14 2026
Locked
LUCID CAPITAL MARKETS:
Locked
➜
Locked
Jun 03 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Apr 14 2026
Locked
B. Riley Securities:
Locked
➜
Locked
Feb 10 2026
Locked
Roth Capital:
Locked
➜
Locked
Dec 03 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Nov 28 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Oct 15 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today